Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Elan Corporation (6099.T)
JPY787.00
+26.00 (+3.42%)
JP JPX Healthcare Medical - Care Facilities
Address
15-12 Idegawa Town 390-0826
Matsumoto, JP
Matsumoto, JP
CEO
Tomohiro Minezaki
Website
kkelan.com
IPO
2014-11-07
ISIN JP3167680002
Description
Elan Corporation operates within the healthcare sector, specializing in nursing and medical services. The company offers a rental and laundry service for crucial daily items such as clothing, towels, and diapers, primarily catering to patients in hospitals and residents of nursing homes. Founded in 1995, Elan Corporation maintains its headquarters in Matsumoto, Japan.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY787.00
+26.00 (+3.42%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
110.6K
Beta
0.65
Float Shares
15.79M
Free Float %
26.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.98% | +0.58% | -7.59% | -1.98% | -10.57% | -1.70% | -11.59% | -31.36% | -46.74% | +323.48% | +219.08% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
787.00
DCF (Unlevered)
1,342.68
+70.6%
DCF (Levered)
1,475.75
+87.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.18
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+16.7% ★ Q1'26: +9.9% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+17.5% Q1'26: +18.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+5.4% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+7.7% Q1'26: +9.8% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+33.4% ★ Q1'26: +38.5% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.14× ★ Q1'26: 0.12× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.01B
est: 9.00B (+0.1%)
|
11.41B
est: 11.30B (+1.0%)
|
15.47B
est: 15.50B (-0.2%)
|
18.59B
est: 18.61B (-0.2%)
|
21.52B
est: 21.41B (+0.5%)
|
26.06B
est: 25.60B (+1.8%)
|
31.64B
est: 31.70B (-0.2%)
|
36.26B
est: 36.65B (-1.1%)
|
41.43B
est: 43.00B (-3.7%)
|
47.51B
est: 47.50B (+0.0%)
|
55.45B
est: 55.10B (+0.6%)
|
60.50B
60.50B – 60.50B
+9.8% YoY
|
67.50B
67.50B – 67.50B
+11.6% YoY
|
76.00B
76.00B – 76.00B
+12.6% YoY
|
| EBITDA |
601.46M
est: 830.18M (-27.6%)
|
769.97M
est: 1.04B (-26.1%)
|
992.62M
est: 1.43B (-30.6%)
|
1.38B
est: 1.72B (-19.7%)
|
1.60B
est: 1.97B (-18.8%)
|
2.19B
est: 2.36B (-7.4%)
|
2.92B
est: 2.92B (-0.2%)
|
3.53B
est: 3.38B (+4.6%)
|
3.85B
est: 3.97B (-2.9%)
|
4.49B
est: 4.54B (-1.1%)
|
5.59B
est: 5.27B (+6.1%)
|
5.79B
5.79B – 5.79B
+9.8% YoY
|
6.46B
6.46B – 6.46B
+11.6% YoY
|
7.27B
7.27B – 7.27B
+12.6% YoY
|
| EBIT |
572.12M
est: 765.24M (-25.2%)
|
736.07M
est: 960.80M (-23.4%)
|
912.93M
est: 1.32B (-30.7%)
|
1.28B
est: 1.58B (-19.2%)
|
1.49B
est: 1.82B (-18.0%)
|
2.07B
est: 2.18B (-5.0%)
|
2.80B
est: 2.70B (+3.8%)
|
3.39B
est: 3.12B (+8.8%)
|
3.67B
est: 3.66B (+0.3%)
|
3.58B
est: 4.01B (-10.8%)
|
4.24B
est: 4.65B (-8.8%)
|
5.11B
5.11B – 5.11B
+9.8% YoY
|
5.70B
5.70B – 5.70B
+11.6% YoY
|
6.42B
6.42B – 6.42B
+12.6% YoY
|
| Net Income |
363.05M
est: 412.65M (-12.0%)
|
500.67M
est: 482.94M (+3.7%)
|
657.73M
est: 639.38M (+2.9%)
|
865.41M
est: 907.38M (-4.6%)
|
989.60M
est: 1.05B (-6.2%)
|
1.45B
est: 1.33B (+8.7%)
|
1.91B
est: 1.90B (+0.4%)
|
2.08B
est: 2.21B (-5.9%)
|
2.52B
est: 2.56B (-1.7%)
|
2.35B
est: 2.20B (+7.0%)
|
2.77B
est: 2.85B (-2.8%)
|
3.20B
3.20B – 3.20B
+12.3% YoY
|
3.80B
3.80B – 3.80B
+18.7% YoY
|
4.30B
4.30B – 4.30B
+13.2% YoY
|
| SGA |
1.87B
est: 1.41B (+32.5%)
|
2.26B
est: 1.78B (+27.2%)
|
3.08B
est: 2.44B (+26.7%)
|
3.55B
est: 2.92B (+21.3%)
|
3.98B
est: 3.36B (+18.3%)
|
4.50B
est: 4.02B (+11.8%)
|
5.08B
est: 4.98B (+2.0%)
|
5.64B
est: 5.76B (-2.1%)
|
6.09B
est: 6.76B (-9.9%)
|
7.14B
est: 7.14B (+0.1%)
|
7.65B
est: 8.28B (-7.6%)
|
9.09B
9.09B – 9.09B
+9.8% YoY
|
10.14B
10.14B – 10.14B
+11.6% YoY
|
11.42B
11.42B – 11.42B
+12.6% YoY
|
| EPS |
6.19
est: 6.83 (-9.3%)
|
8.50
est: 7.99 (+6.4%)
|
11.06
est: 10.58 (+4.6%)
|
14.39
est: 15.01 (-4.1%)
|
16.33
est: 17.45 (-6.4%)
|
23.87
est: 22.00 (+8.5%)
|
31.49
est: 31.40 (+0.3%)
|
34.45
est: 36.60 (-5.9%)
|
41.66
est: 42.40 (-1.7%)
|
38.94
est: 36.40 (+7.0%)
|
45.77
est: 47.10 (-2.8%)
|
52.90
52.90 – 52.90
+12.3% YoY
|
62.80
62.80 – 62.80
+18.7% YoY
|
71.10
71.10 – 71.10
+13.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
79.85M
OE per share TTM
1.32
Owner's Yield
0.19%
Maintenance CapEx ratio
4.22%
Maint CapEx / Avg PPE
1.3%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 29 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.02% | 95.9K | 0.58% |
| 2 | WisdomTree International Equity Fund DWM | 0.01% | 56.0K | 0.48% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 246.5K | 0.06% |
| 4 | Dimensional - International Small Cap ETF DFIS | 0.00% | 72.4K | 0.39% |
| 5 | iShares Core TOPIX ETF 1475.T | 0.00% | 203.4K | 0.05% |
| 6 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | 11.1K | 0.24% |
| 7 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 122.9K | 0.22% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 55.8K | 0.28% |
| 9 | Vanguard ESG International Stock ETF VSGX | 0.00% | 20.5K | 0.10% |
| 10 | Vanguard FTSE Developed All Cap ex U.S. Index ETF VDU.TO | 0.00% | 1.3K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
6.28M
Shares Outstanding
60.48M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akira Ishizuka | CSO, Executive Officer, GM of Corporate Strategy Department & Director | — | male |
| Akira Kamiharako | Head of Global Development Division | — | — |
| Atsushi Takahashi | Head of West Japan Sales Division | — | — |
| Hiroshi Muraki | Head of East Japan Sales Division | — | — |
| Tomohiro Minezaki | President, CEO & Chairman | — | male |
| Yoichi Kamijo | Exec Officer, Chief Financial Officer, GM of Management HQ & Business Admin Dept. and Director | — | — |
| Yu Iizuka | Executive Officer, CMO & GM of Sales Department | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6099.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
